fusidic acid has been researched along with Atypical Mycobacterial Infection, Disseminated in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Franzblau, SG; Witzig, RS | 1 |
| de Jong, A; Hazenberg, HJ; Kuipers, EJ; Ploeger, B; Smit, FW | 1 |
2 other study(ies) available for fusidic acid and Atypical Mycobacterial Infection, Disseminated
| Article | Year |
|---|---|
Susceptibility of Mycobacterium kansasii to ofloxacin, sparfloxacin, clarithromycin, azithromycin, and fusidic acid.
Topics: 4-Quinolones; Anti-Bacterial Agents; Fusidic Acid; Humans; Macrolides; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria | 1993 |
Nontuberculous mycobacterial sternal osteomyelitis in a patient without predisposing condition.
Topics: Adult; Chronic Disease; Drug Therapy, Combination; Female; Fusidic Acid; Humans; Mycobacterium Infections, Nontuberculous; Osteomyelitis; Pyrazinamide; Sternum | 1991 |